54 Recruiting Studies Using Doxorubicin Hydrochloride
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Doxorubicin Hydrochloride
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
📍 The University of Arizona Cancer Center - North Campus /ID# 242219 — Tucson, Arizona
Non-Hodgkin Lymphoma
View Study & Checklist ➔S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
📍 Regional Medical Center — Anniston, Alabama
Breast Cancer
View Study & Checklist ➔Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Adult T Acute Lymphoblastic Leukemia
View Study & Checklist ➔Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery
📍 M D Anderson Cancer Center — Houston, Texas
Metastatic Urothelial Carcinoma
View Study & Checklist ➔Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma
📍 Cleveland Clinic — Cleveland, Ohio
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
📍 Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Ganglioneuroblastoma
View Study & Checklist ➔Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
📍 Northeast Alabama Regional Medical Center — Anniston, Alabama
Breast Adenocarcinoma
View Study & Checklist ➔PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
Hodgkin Lymphoma
View Study & Checklist ➔Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
View Study & Checklist ➔Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Aggressive Non-Hodgkin Lymphoma
View Study & Checklist ➔Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
📍 Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Grade 1 Follicular Lymphoma
View Study & Checklist ➔Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma
📍 Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey
Ann Arbor Stage III Non-Hodgkin Lymphoma
View Study & Checklist ➔A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder
📍 Indiana University — Bloomington, Indiana
Urothelial Carcinoma
View Study & Checklist ➔Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
Mantle Cell Lymphoma
View Study & Checklist ➔Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
View Study & Checklist ➔Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
📍 Banner University Medical Center - Tucson — Tucson, Arizona
Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
📍 Providence Hospital — Mobile, Alabama
Ann Arbor Stage II Non-Hodgkin Lymphoma
View Study & Checklist ➔Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
Blastoid Variant Mantle Cell Lymphoma
View Study & Checklist ➔Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study
📍 M D Anderson Cancer Center — Houston, Texas
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Sarcoma
View Study & Checklist ➔Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Ann Arbor Stage III Hodgkin Lymphoma
View Study & Checklist ➔Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Primary Mediastinal Large B-Cell Lymphoma
View Study & Checklist ➔Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment
📍 Wake Forest University Health Sciences — Winston-Salem, North Carolina
B-Cell Non-Hodgkin Lymphoma
View Study & Checklist ➔Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body
📍 Children's Hospital of Alabama — Birmingham, Alabama
CIC-Rearranged Sarcoma
View Study & Checklist ➔Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma
📍 Karmanos Cancer Institute — Detroit, Michigan
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Adult T-Cell Leukemia/Lymphoma
View Study & Checklist ➔Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Metastatic Ewing Sarcoma
View Study & Checklist ➔Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Ann Arbor Stage IIB Hodgkin Lymphoma
View Study & Checklist ➔Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer
📍 City of Hope Medical Center — Duarte, California
Breast Cancer
View Study & Checklist ➔Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
📍 Banner University Medical Center - Tucson — Tucson, Arizona
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
📍 NCI Lymphoid Malignancies Branch — Bethesda, Maryland
AIDS-Related Burkitt Lymphoma
View Study & Checklist ➔Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
📍 UC San Diego Moores Cancer Center — La Jolla, California
AIDS-Related Lymphoma
View Study & Checklist ➔Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
📍 Southern Cancer Center PC-Mobile — Mobile, Alabama
Breast Adenocarcinoma
View Study & Checklist ➔Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma
📍 Mount Sinai Hospital — New York, New York
Mantle Cell Lymphoma
View Study & Checklist ➔Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
Uterine Leiomyosarcoma
View Study & Checklist ➔A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
📍 University of Miami Miller School of Medicine — Miami, Florida
Plasmablastic Lymphoma
View Study & Checklist ➔A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
📍 Children's Hospital of Alabama — Birmingham, Alabama
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
View Study & Checklist ➔SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
Soft Tissue Sarcoma
View Study & Checklist ➔Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
📍 Children's Hospital of Alabama — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
📍 Duke Cancer Center Clinic 1B/C Onc/Heme ( Site 1307) — Durham, North Carolina
Follicular Lymphoma
View Study & Checklist ➔Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
📍 Children's Hospital of Alabama — Birmingham, Alabama
Ganglioneuroblastoma
View Study & Checklist ➔Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
📍 M D Anderson Cancer Center — Houston, Texas
Metastatic Sarcoma
View Study & Checklist ➔Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
📍 UCLA Hematology/Oncology - Parkside ( Site 0021) — Santa Monica, California
Breast Neoplasms
View Study & Checklist ➔Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
T Acute Lymphoblastic Leukemia
View Study & Checklist ➔Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
📍 Kingman Regional Medical Center — Kingman, Arizona
Renal Pelvis and Ureter Urothelial Carcinoma
View Study & Checklist ➔A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
📍 University of Miami Sylvester Cancer Center — Miami, Florida
Lymphoma
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
📍 Emory University Hospital Midtown — Atlanta, Georgia
Acute Adult T-Cell Leukemia/Lymphoma
View Study & Checklist ➔ALL Backbone in AYAs
📍 Dana Farber Cancer Institute — Boston, Massachusetts
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Phase 2 Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL
📍 UT MD Anderson — Houston, Texas
Hodgkin Lymphoma
View Study & Checklist ➔